Skip to main content
OpenTrials
Completed

NCT Number: NCT01250691

Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU

This study will carry out in the ICU. Objectives of the study are to determine the frequency of HAP and the effect of isolated rooms on the frequency of pneumonia in the ICU.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Eskisehir Osmangazi University, Eskişehir, Merkez, Turkey (Türkiye)

Loading trial locations.

About this study

In the present study, it was aimed to determine the incidence, causative agents, antimicrobial resistance, and risk factors for lower respiratory tract infections in patients followed in the ICU for the last 4 years. The effect of reconfiguration from a ward-type ICU consisting one large room to an ICU with isolated rooms with two beds on the incidence of HAP was also determined.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult patients,
  • admitted to the ICU

Exclusion criteria

  • trauma, surgery or burned patients
  • patients under 18

Treatment and study plan

ward-type ICU

Other

frequency of hospital acquired pneumonia in the ICU

Other names: frequency of hospital acquired pneumonia in the ICU

Sponsors and collaborators

Lead sponsor

Eskisehir Osmangazi University

Other

Registry information

Official study title

Epidemiologic Study of Hospital Acquired Pneumonia in a Respiratory ICU

Important dates

Study start
2004
Primary completion
2008
Study completion
2010
First posted
Dec 1, 2010
Registry last updated
Dec 1, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.